Greenphage Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.08M

  • Investors
  • 5

Greenphage General Information

Description

Developer of a precision antibacterial compound designed to deliver selective action on specific bacterial species or strains. The company offers targeted antibacterial action that preserves the bacterial ecosystem, with natural and biodegradable residues, enabling businesses to address specific antibacterial needs with precision and reliability.

Contact Information

Website
www.greenphage.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cap Alpha
  • 3 Avenue De LEurope
  • 34830 Clapiers
  • France
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
CleanTech, AgTech, Life Sciences
Corporate Office
  • Cap Alpha
  • 3 Avenue De LEurope
  • 34830 Clapiers
  • France

Greenphage Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Greenphage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 03-Mar-2025 $2.08M Completed Generating Revenue
5. Accelerator/Incubator 28-Feb-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
3. Seed Round 14-Apr-2023 Completed Generating Revenue
2. Seed Round 21-Mar-2019 $283K $283K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Greenphage’s complete valuation and funding history, request access »

Greenphage Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
ADP
Ordinary
Ordinary 3,750 $1.041038 $69.4 $69.4 1x $69.4 11.58%
To view Greenphage’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Greenphage Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Greenphage Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4659753-A1 Therapeutic and non-therapeutic uses of tailocins of pseudomonas species against e. coli and new tailocins of pseudomonas fluorescens Inactive 07-Jun-2024
WO-2025253013-A1 Therapeutic and non-therapeutic uses of tailocins of pseudomonas species against e. coli and new tailocins of pseudomonas fluorescens Pending 07-Jun-2024

Greenphage Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Greenphage Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
IRDI Capital Investissement PE/Buyout Minority
Boost Invest MedVallée Accelerator/Incubator
CleanTech Vallée Accelerator/Incubator
Greentech (France) Corporation Minority
Business & Innovation Center Accelerator/Incubator
To view Greenphage’s complete investors history, request access »

Ready to get started?

Request a free trial

Greenphage FAQs

  • When was Greenphage founded?

    Greenphage was founded in 2017.

  • Where is Greenphage headquartered?

    Greenphage is headquartered in Clapiers, France.

  • What is the size of Greenphage?

    Greenphage has 8 total employees.

  • What industry is Greenphage in?

    Greenphage’s primary industry is Biotechnology.

  • Is Greenphage a private or public company?

    Greenphage is a Private company.

  • What is the current valuation of Greenphage?

    The current valuation of Greenphage is .

  • What is Greenphage’s current revenue?

    The current revenue for Greenphage is .

  • How much funding has Greenphage raised over time?

    Greenphage has raised $3.34M.

  • Who are Greenphage’s investors?

    IRDI Capital Investissement, Boost Invest MedVallée, CleanTech Vallée, Greentech (France), and Business & Innovation Center have invested in Greenphage.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process